相关实验视频

Updated: Jun 4, 2025

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

莫莫迪辛-I通过调节关键代谢途径来抑制头癌的生长

Debojyoty Bandyopadhyay¹, Ellen T Tran¹, Ruchi A Patel¹

¹Department of Pathology, Saint Louis University, 1100 South Grand Boulevard, St. Louis, MO, 63104, USA.

Cell communication and signaling : CCS

|December 19, 2024

概括

苦瓜中的Momordicine-I抑制了脑癌细胞中的关键癌症代谢途径,如糖解和脂质合成,减少了小鼠的瘤生长.

科学领域:

在瘤学瘤学.
代谢途径代谢途径
癌症研究癌症研究

背景情况:

癌细胞表现出对生存和治疗耐药性的代谢重编程.
莫莫迪卡 (Momordica charantia) (苦瓜) 含有具有潜在抗癌性能的生物活性化合物.

研究的目的:

为了研究momordicine-I (M-I) 对人类头癌 (HNC) 细胞和小鼠HNC模型中的代谢途径的影响.
通过了解其对细胞代谢的影响,探索M-I在HNC中的治疗潜力.

主要方法:

对HNC细胞和小鼠HNC模型的治疗与M-I.
对关键的糖分和脂质基因和蛋白质表达的分析.
代谢学和脂质学分析.
对线粒体功能,自和信号通路 (AMPK,mTOR,Akt) 的评估.

主要成果:

在HNC细胞和瘤中,M-I显著降低了葡萄糖分解和de novo脂质生成标记物.
M-I改变了脂质特征,调节了线粒体功能,并诱导了自.
M-I激活了AMPK,抑制了mTOR和Akt通路,导致了亡.
在小鼠模型中,M-I治疗减少了瘤体积.

结论:

莫莫迪辛-I通过抑制糖解和脂质合成,有效地重编程癌症代谢.
在HNC细胞中,M-I诱导了自和亡,提供了潜在的治疗策略.
M-I在体内表现出抗瘤原生作用,突出显示了它对HNC的治疗意义.

关键词:

自自是一种自的过程.葡萄糖溶解是什么? 葡萄糖溶解头癌是头部和部的癌症.脂质代谢脂质代谢是一种它的代谢物是代谢物.莫莫迪辛-I的母亲

更多相关视频

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

相关概念视频

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...